Gross Profit On Sales Endring Dato
Abbott USD 5.68B 147M 2023-12
Agilent USD 908M 7M 2023-12
AtriCure USD 79.82M 5.95M 2023-12
Baxter International USD 1.49B 351M 2023-12
Becton, Dickinson and Co. USD 2.03B 326M 2023-12
Bio-Rad Laboratories USD 366.3M 30.42M 2023-12
Boston Scientific USD 2.57B 135M 2023-12
Cooper Companies USD 606.5M 3.5M 2023-09
Danaher USD 3.78B 221M 2023-12
Dexcom USD 673.2M 49.9M 2023-12
Edwards Lifesciences USD 1.18B 46.7M 2023-12
Globus Medical USD 351.05M 102.8M 2023-12
Hologic USD 567.5M 67.2M 2023-12
Insulet USD 361.2M 67.9M 2023-12
Integra LifeSciences USD 239.24M 14.93M 2023-12
Intuitive Surgical USD 1.28B 110.2M 2023-12
J&J USD 14.6B 374M 2023-12
Masimo USD 262.7M 27.9M 2023-12
Merit Medical Systems USD 142.2M 10.58M 2023-09
Pfizer USD 7.58B 3.26B 2023-12
Smith & Nephew USD 1.9B 50M 2023-06
Stryker USD 3.71B 535M 2023-12
Tandem Diabetes Care USD 93.3M 3.54M 2023-12
Teleflex USD 431.42M 15.11M 2023-12
Terumo JPY 118.46B 8.66B 2023-09
Thermo Fisher Scientific USD 4.5B 180M 2023-12
Zimmer Biomet Holdings USD 1.4B 166.3M 2023-12



Abbott Brutto Fortjeneste På Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.